Effect of quercetin on kinetic properties of renal na,k-atpase in normotensive and hypertensive rats

Journal of Physiology and Pharmacology

Volumn 61, Issue 5, 2010, Pages 593-598

  Mezesova, L ^a   Bartekova, M ^a   Javorkova, V ^a   Vlkovicova, J ^a   Breier, A ^b   Vrbjar, N ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

Author keywords

Bioflavonoids; Hypertension; K atpase kidney; Na; Quercetin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; KIDNEY ENZYME; QUERCETIN; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; HYPERTENSION; KIDNEY MASS; MALE; MICHAELIS CONSTANT; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; BODY WEIGHT; DRUG EVALUATION, PRECLINICAL; FLAVONOIDS; HYPERTENSION; KIDNEY; KINETICS; MALE; QUERCETIN; RATS; RATS, INBRED SHR; RATS, WISTAR; SODIUM; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 78649639490     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Renaud S, de Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-1526.
2. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342: 1007-1011.
3. Terao J, Kawai Y, Murota K. Vegetable flavonoids and cardiovascular disease. Asia Pac J Clin Nutr 2008; 17: 291-293.
4. Ossola B, Kaariainen TM, Mannisto PT. The multiple faces of quercetin in neuroprotection. Expert Opin Drug Saf 2009; 8: 397-409.
5. Han JJ, Hao J, Kim CH, Hong JS, Ahn HY, Lee YS. Quercetin prevents cardiac hypertrophy induced by pressure overload in rats. J Vet Med Sci 2009; 71: 737-743.
6. Becerra-Torres SL, Rodriguez-Vazquez ML, Medina-Ramirez IE, Jaramillo-Juarez F. The flavonoid quercetin protects and prevents against potassium dichromate-induced systemic peroxidation of lipids and diminution in renal clearance of para-aminohippuric acid and inulin in the rat. Drug Chem Toxicol 2009; 32: 88-91.
7. Robak J, Gryglewski JR. Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 1988; 37: 837-841.
8. Duarte J, Andriambeloson E, Diebolt M, Andriantsitohaina R. Wine polyphenols stimulate superoxide anion production to promote calcium signalling and endothelial-dependent vasodilatation. Physiol Res 2004; 53: 595-602.
9. Romero M, Jimenez R, Sanchez M, et al. Quercetin inhibits vascular superoxide production induced by endothelin-1: role of NADPH oxidase, uncoupled eNOS and PKC. Atherosclerosis 2009; 202: 58-67.
10. Bartekova M, Ditte Z, Sulova Z, et al. The effect of quercetin on physiological and biochemical parameters of normotensive and hypertensive rats. Physiol Res 2008; 57: 9P.
11. Egert S, Bosy-Westphal A, Seiberl J, et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a doubleblinded, placebo-controlled cross-over study. Br J Nutr 2009; 102: 1065-1074.
12. Perez-Vizcaino F, Duarte J, Jimenez R, Santos-Buelga C, Osuna A. Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep 2009; 61: 67-75.
13. Pei TX, Xu CQ, Li B, et al. Protective effect of quercetin against adriamycin-induced cardiotoxicity and its mechanism in mice. Yao Xue Xue Bao 2007; 42: 1029-1033.
14. Shoshan V, Campbell KP, MacLennan DH, Frodis W, Britt BA. Quercetin inhibits Ca2+ uptake but not Ca2+ release by sarcoplasmic reticulum in skinned muscle fibers. Proc Natl Acad Sci USA 1980; 77: 4435-4438.
15. McKenna E, Smith JS, Coll KE, et al. Dissociation of phospholamban regulation of cardiac sarcoplasmic reticulum Ca21ATPase by quercetin. J Biol Chem 1996; 271: 24517-24525.
16. Kuriki Y, Racker E. Inhibition of (Na+,K+)adenosine triphosphatase and its partial reactions by quercetin. Biochemistry 1976; 15: 4951-4956.
17. Robinson JD, Robinson LJ, Martin NJ. Effects of oligomycin and quercetin on the hydrolytic activities of the (Na+/K+)-dependent ATPase. Biochim Biophys Acta 1984; 772: 295-306.
18. Zheng J, Ramirez VD. Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br J Pharmacol 2000; 130: 1115-1123.
19. Gasparin FR, Spitzner FL, Ishii-Iwamoto EL, Bracht A, Constantin J. Actions of quercetin on gluconeogenesis and glycolysis in rat liver. Xenobiotica 2003; 33: 903-911.
20. Jorgensen PL, Pedersen PA. Structure-function relationships of Na, K, ATP, or Mg binding and energy transduction in Na,K-ATPase. Biochim Biophys Acta 2001; 1505: 57-74.
21. Melzi ML, Bertorello A, Fukunda Y, Muldin I, Sereni F, Aperia A. Na, K-ATPase activity in renal tubule cells from Milan hypertensive rats. Am J Hypertens 1989; 2: 563-566.
22. Ikari A, Tachihara Y, Kawano K, Suketa Y. Differential regulation of Na+,K+-ATPase and the Na+-coupled glucose transporter in hypertensive rat kidney. Biochim Biophys Acta 2001; 1510: 118-124.
23. +- ATPase: III. Purification from the outer medulla of mammalian kidney after selective removal of membrane components by sodium dodecylsulphate. Biochim Biophys Acta 1974; 356: 36-52.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
25. Taussky HH, Shorr EE. A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 1953; 202: 675-285.
26. Edmondson RP, Thomas RD, Hilton PJ, Patrick J, Jones NF. Abnormal leukocyte composition and sodium transport in essential hypertension. Lancet 1975; 1: 1003-1005.
27. Ambresioni E, Costa FV, Montebugnoli L, Tartagni F, Magnani B. Increased intralymphocytic sodium content in essential hypertension: an index of impaired sodium cellular metabolism. Clin Sci 1981; 61: 181-186.
28. Haddy FJ. Digitalislike circulating factor in hypertension: potential messenger between salt balance and intracellular sodium. Cardiovasc Drugs Ther 1990; 4: 343-349.
29. Wardener HE, MacGregor GA. The relation of a circulating sodium transport inhibitor (the natriuretic hormone?) to hypertension. Medicine (Baltimore) 1983; 62: 310-326.
30. Cooper RS, Shamsi N, Katz S. Intracellular calcium and sodium in hypertensive patients. Hypertension (Dallas) 1987; 9: 224-229.
31. Sudar E, Velebit J, Gluvic Z, et al. Hypothetical mechanism of sodium pump regulation by estradiol under primary hypertension. J Theor Biol 2008; 251: 584-592.
32. Pamnani MB, Clough DL, Huot SJ, Haddy FJ. Sodiumpotassium pump activity in experimental hypertension. In: Vasodilatation, P.M. Vanhoutte, I. Leusen, (eds.) New York, Raven Press, 1981, pp. 391-403.
33. Pamnani M, Huot S, Buggy J, Clough D, Haddy F. Demonstration of a humoral inhibitor of the Na+-K+ pump in some models of experimental hypertension. Hypertension 1981; 3: 96-101.
34. Clough DL, Pamnani MB, Haddy FJ. Myocardial Na,KATPase activity in rats with steroid and spontaneous hypertension. J Hypertens 1984; 2: 141-147.
35. Vlkovicova J, Javorkova V, Pechanova O, Vrbjar N. Gender difference in functional properties of Na,K-ATPase in the heart of spontaneously hypertensive rats. Life Sci 2005; 76: 971-982.
36. Javorkova V, Vlkovicova J, Kunes J, Pechanova O, Zicha J, Vrbjar N. Effect of maturation on renal Na+/K+-ATPase and its susceptibility to nitric oxide-deficient hypertension in rats. Clin Exp Pharmacol Physiol 2007; 34: 617-623.
37. Javorkova V, Pechanova O, Andriantsitohaina R, Vrbjar N. Effect of polyphenolic compounds on the renal Na+,K+- ATPase during development and persistence of hypertension in rats. Exp Physiol 2004; 89: 73-81.
38. Tsuruya Y, Ikeda U, Kawakami K, et al. Augmented Na,KATPase gene expression in spontaneously hypertensive rat hearts. Clin Exp Hypertens 1991; 13: 1213-222.
39. Bartekova M, Carnicka S, Pancza D, Ondrejcakova M, Breier A, Ravingerova T. Acute treatment with polyphenol quercetin improves postischemic recovery of isolated perfused rat hearts after global ischemia. Can J Physiol Pharmacol 2010; 88: 465-471.
40. Maneva A, Taleva B. Effect of some flavonic compounds and ascorbic acid on lactoferrin stimulation of erythrocyte glycolysis and Na+/K+-atpase activity. Z Naturforsch C 2008; 63: 773-779.
41. Boer VC, Dihal AA, van der Woude H, et al. Tissue distribution of quercetin in rats and pigs. J Nutr 2005; 135: 1718-1725.
42. Bieger J, Cermak R, Blank R, et al. Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr 2008; 138: 1417-1420.
43. Eldin AA, Shaheen AA, Abd Elgawad HM, Shehata NI. Protective effect of taurine and quercetin against renal dysfunction associated with the combined use of gentamycin and diclofenac. Indian J Biochem Biophys 2008; 45: 332-340.
44. Vlkovicova J, Javorkova V, Mezesova L, Pechanova O, ndriantsitohaina R, Vrbjar N. Dual effect of polyphenolic and persistance of hypertension in rats. Can J Physiol Pharmacol 2009; 87: 1046-1054.
45. Javorkova V, Pechanova O, Andriantsitohaina R, Vrbjar N. Effect of polyphenolic compounds on the renal Na+,K+- ATPase during the restoration of normotension after experimentally induced hypertension in rats. Exp Physiol 2003; 88: 475-482.
46. Andriambeloson E, Stoclet JC, Andriantsitohaina R. Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta. J Cardiovasc Pharmacol 1999; 33: 248-254.
47. Orellana M, Araya J, Guajardo, Rodrigo R. Modulation of cytochrome P450 activity in the kidney of rats following long-term red wine exposure. Comp Biochem Physiol C 2002; 132: 399-405.
48. Rodrigo R, Gonzalo R, Orellana M, Arya J, Bosco C. Rat kidney antioxidant response to long-term exposure to flavonol rich red wine. Life Sci 2002; 71: 2881-2895.
49. Rodrigo R, Rivera G. Renal damage mediated by oxidative stress: a hypothesis of protective effects of red wine. Free Radic Biol Med 2002; 33: 409-422.
50. Rodrigo R, Bosco C, Herrera P, Rivera G. Amelioration of myoglobinuric renal damage in rats by chronic exposure to flavonol-rich red wine. Nephrol Dial Transplant 2004; 19: 2237-2244.